ZA200610769B - Steroid prodrugs with androgenic effect - Google Patents

Steroid prodrugs with androgenic effect

Info

Publication number
ZA200610769B
ZA200610769B ZA200610769A ZA200610769A ZA200610769B ZA 200610769 B ZA200610769 B ZA 200610769B ZA 200610769 A ZA200610769 A ZA 200610769A ZA 200610769 A ZA200610769 A ZA 200610769A ZA 200610769 B ZA200610769 B ZA 200610769B
Authority
ZA
South Africa
Prior art keywords
androgenic effect
steroid prodrugs
prodrugs
steroid
androgenic
Prior art date
Application number
ZA200610769A
Other languages
English (en)
Inventor
Wyrwa Ralf
Ring Sven
Schneider Birgitt
Reddersen Gudrun
Droescher Peter
Elger Walter
Hillisch Alexander
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ZA200610769B publication Critical patent/ZA200610769B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ZA200610769A 2004-05-21 2006-12-20 Steroid prodrugs with androgenic effect ZA200610769B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025986A DE102004025986A1 (de) 2004-05-21 2004-05-21 Steroid-Prodrugs mit androgener Wirkung

Publications (1)

Publication Number Publication Date
ZA200610769B true ZA200610769B (en) 2008-08-27

Family

ID=34968657

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200610769A ZA200610769B (en) 2004-05-21 2006-12-20 Steroid prodrugs with androgenic effect

Country Status (22)

Country Link
EP (1) EP1747229A1 (zh)
JP (1) JP2007538026A (zh)
CN (1) CN1993375A (zh)
AR (1) AR049547A1 (zh)
AU (1) AU2005245568A1 (zh)
BR (1) BRPI0510136A (zh)
CA (1) CA2564963A1 (zh)
CR (1) CR8785A (zh)
DE (1) DE102004025986A1 (zh)
EA (1) EA200602049A1 (zh)
EC (1) ECSP067028A (zh)
GT (1) GT200500122A (zh)
IL (1) IL179293A0 (zh)
MX (1) MXPA06013469A (zh)
NO (1) NO20065885L (zh)
PA (1) PA8633601A1 (zh)
PE (1) PE20060271A1 (zh)
SV (1) SV2006002123A (zh)
TW (1) TW200613317A (zh)
UY (1) UY28911A1 (zh)
WO (1) WO2005113575A1 (zh)
ZA (1) ZA200610769B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057408A1 (de) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag Sulfamoylsulfonat-Prodrugs
CN101708338B (zh) * 2008-12-26 2014-06-04 中国人民解放军军事医学科学院放射与辐射医学研究所 含甾体结构的前药及其高度分散制剂
CN102964417A (zh) * 2012-11-30 2013-03-13 华中药业股份有限公司 17-羟基四氢吡喃醚甾族化合物的合成方法
CN107556258B (zh) * 2017-08-22 2021-06-04 湖北江田精密化学有限公司 一种4-氨基-2-氯-5(1h-四唑基-5)苯磺酰胺的制备方法
EP3533619A1 (en) * 2018-03-02 2019-09-04 Basf Se Heat sensitive recording material and color developer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH545316A (de) * 1970-07-17 1973-12-15 Hoffmann La Roche Verfahren zur Herstellung von Acylderivaten
US5001234A (en) * 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
WO2005113575A1 (de) 2005-12-01
GT200500122A (es) 2006-01-24
CA2564963A1 (en) 2005-12-01
IL179293A0 (en) 2007-03-08
SV2006002123A (es) 2006-02-15
BRPI0510136A (pt) 2007-10-02
JP2007538026A (ja) 2007-12-27
CN1993375A (zh) 2007-07-04
AU2005245568A1 (en) 2005-12-01
PE20060271A1 (es) 2006-05-25
UY28911A1 (es) 2005-12-30
EA200602049A1 (ru) 2007-06-29
DE102004025986A1 (de) 2005-12-15
NO20065885L (no) 2006-12-19
CR8785A (es) 2007-02-05
EP1747229A1 (de) 2007-01-31
ECSP067028A (es) 2006-12-29
PA8633601A1 (es) 2006-07-03
AR049547A1 (es) 2006-08-16
TW200613317A (en) 2006-05-01
MXPA06013469A (es) 2007-01-23

Similar Documents

Publication Publication Date Title
EP1711186A4 (en) SLOWLY RELEASED STEROID COMPOSITION
GB2435698B (en) Adjusting local time
EP2114895A4 (en) TALARAZOLMETABOLITEN
DE602007008470D1 (en) Off
EP1999580A4 (en) INTEGRATED MULTISERVER INSTALLATION
IL176426A0 (en) Di-steroidal prodrugs of estradiol
ZA201002223B (en) Steroidal [3,2-c]pyrazole compounds,with glucocorticoid activity
ZA200610769B (en) Steroid prodrugs with androgenic effect
EP2012795A4 (en) THERAPEUTIC TRITERPENOIDS
EP2084443A4 (en) EXECUTION
EP2053170A4 (en) URINAL
EP1977052A4 (en) URINAL WITH ANTI-BACK SPRAY FUNCTION
IL176427A0 (en) Di-steroidal prodrugs of ethinyl estradiol
IL187632A0 (en) 3-ester prodrugs of ethynylestradiol
EP2178376A4 (en) LUPANIC TRITERPENOIDS MODIFIED IN 30-POSITION AND ITS ANALOG
AP2008004705A0 (en) Pnem prodrugs
IL187633A0 (en) 3-ester prodrugs of estradiol
GB0602621D0 (en) Fastening
GB0421294D0 (en) Bioreductively-activated prodrugs
HK1126225A1 (en) Steroidal compounds as steroid sulphatase inhibitors
GB0610473D0 (en) Shower screen arrangement
GB0515699D0 (en) Prodrugs
GB0421296D0 (en) Bioreductively-activated prodrugs
IL173608A0 (en) 15-d-homosteroids having an androgenic effect
IL187629A0 (en) Steroids having a mixed androgenic and progestagenic profile